The store will not work correctly when cookies are disabled.
4-(3-(2-chloro-6-fluorobenzoyl)-1H-indol-1-yl)benzoic acid
ID: ALA4475634
PubChem CID: 155538113
Max Phase: Preclinical
Molecular Formula: C22H13ClFNO3
Molecular Weight: 393.80
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)c1ccc(-n2cc(C(=O)c3c(F)cccc3Cl)c3ccccc32)cc1
Standard InChI: InChI=1S/C22H13ClFNO3/c23-17-5-3-6-18(24)20(17)21(26)16-12-25(19-7-2-1-4-15(16)19)14-10-8-13(9-11-14)22(27)28/h1-12H,(H,27,28)
Standard InChI Key: JFLNFZQIUAHYTA-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
26.2684 -25.5351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2672 -26.3547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9753 -26.7636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9735 -25.1263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6821 -25.5315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6869 -26.3501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4670 -26.5986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9443 -25.9335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4592 -25.2741 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.7072 -24.4954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5073 -24.3256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7554 -23.5477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2047 -22.9427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4028 -23.1208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1585 -23.8984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4517 -22.1637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2498 -21.9881 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.9005 -21.5604 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.7240 -27.3743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1807 -27.9848 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.5243 -27.5396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7761 -28.3153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5756 -28.4807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1198 -27.8699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8589 -27.0910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0600 -26.9293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7989 -26.1549 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
29.2308 -28.9240 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
13 16 1 0
16 17 1 0
16 18 2 0
7 19 1 0
19 20 2 0
19 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
26 27 1 0
22 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 393.80 | Molecular Weight (Monoisotopic): 393.0568 | AlogP: 5.35 | #Rotatable Bonds: 4 |
Polar Surface Area: 59.30 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 4.62 | CX Basic pKa: ┄ | CX LogP: 5.82 | CX LogD: 3.11 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.48 | Np Likeness Score: -1.11 |
References
1. Shaikh NS, Iyer JP, Munot YS, Mukhopadhyay PP, Raje AA, Nagaraj R, Jamdar V, Gavhane R, Lohote M, Sherkar P, Bala M, Petla R, Meru A, Umrani D, Rouduri S, Joshi S, Reddy S, Kandikere V, Bhuniya D, Kulkarni B, Mookhtiar KA.. (2019) Discovery and pharmacological evaluation of indole derivatives as potent and selective RORγt inverse agonist for multiple autoimmune conditions., 29 (16): [PMID:31272795] [10.1016/j.bmcl.2019.06.044] |